Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Journal of Occupational and Environmental Medicine
|
January 12, 2007
Impacts of a smoking cessation benefit among employed populations
Michael T Halpern, Riad Dirani, Jordana K Schmier
American Journal of Health Promotion : AJHP
|
November 14, 2008
Smoking cessation: the value of a comprehensive carved-in benefit
Stephen S Johnston, Tami L Mark, Riad Dirani
Current Therapeutic Research, Clinical and Experimental
|
April 26, 2014
An observational study of the effect of two thiazolidinediones on blood lipid levels: Rosiglitazone and pioglitazone in routine clinical practice
Deborah Griffis, Trentnt McLaughlin, Riad Dirani, et al.
Managed Care Interface
|
April 15, 2008
The cost effectiveness of varenicline for smoking cessation
Michael T Halpern, Riad Dirani, Jordana K Schmier
Gender Medicine
|
June 22, 2007
Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking
Lisa Mucha, Judith Stephenson, Nicole Morandi, et al.
Journal of Pharmaceutical Health Services Research : an Official Journal of the Royal Pharmaceutical Society of Great Britain
|
March 15, 2013
Association between adherence to and persistence with atypical antipsychotics and psychiatric relapse among US Medicaid-enrolled patients with schizophrenia
Jessica Panish, Sudeep Karve, Sean D Candrilli, et al.
The American Journal of Managed Care
|
June 3, 2014
Do strict formularies replicate failure for patients with schizophrenia?
Dana P Goldman, Riad Dirani, John Fastenau, et al.
The Journal of Behavioral Health Services & Research
|
March 5, 2013
A Medicaid and commercial insured claims-based study to estimate improved antipsychotic medication adherence among patients with schizophrenia
Bruce Pyenson, Sara Goldberg, Kosuke Iwasaki, et al.
The Journal of Behavioral Health Services & Research
|
February 14, 2002
Access to new medications to treat schizophrenia
Tami L Mark, Riad Dirani, Eric Slade, et al.
Current Medical Research and Opinion
|
November 2, 2010
Perceptions and prescribing considerations among US psychiatrists regarding drug-drug interactions associated with oral atypical antipsychotics
Christian Frois, Annie Guerin, Amit Saraogi, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Journal of Occupational and Environmental Medicine
|
January 12, 2007
Impacts of a smoking cessation benefit among employed populations
Michael T Halpern, Riad Dirani, Jordana K Schmier
American Journal of Health Promotion : AJHP
|
November 14, 2008
Smoking cessation: the value of a comprehensive carved-in benefit
Stephen S Johnston, Tami L Mark, Riad Dirani
Current Therapeutic Research, Clinical and Experimental
|
April 26, 2014
An observational study of the effect of two thiazolidinediones on blood lipid levels: Rosiglitazone and pioglitazone in routine clinical practice
Deborah Griffis, Trentnt McLaughlin, Riad Dirani, et al.
Managed Care Interface
|
April 15, 2008
The cost effectiveness of varenicline for smoking cessation
Michael T Halpern, Riad Dirani, Jordana K Schmier
Gender Medicine
|
June 22, 2007
Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking
Lisa Mucha, Judith Stephenson, Nicole Morandi, et al.
Journal of Pharmaceutical Health Services Research : an Official Journal of the Royal Pharmaceutical Society of Great Britain
|
March 15, 2013
Association between adherence to and persistence with atypical antipsychotics and psychiatric relapse among US Medicaid-enrolled patients with schizophrenia
Jessica Panish, Sudeep Karve, Sean D Candrilli, et al.
The American Journal of Managed Care
|
June 3, 2014
Do strict formularies replicate failure for patients with schizophrenia?
Dana P Goldman, Riad Dirani, John Fastenau, et al.
The Journal of Behavioral Health Services & Research
|
March 5, 2013
A Medicaid and commercial insured claims-based study to estimate improved antipsychotic medication adherence among patients with schizophrenia
Bruce Pyenson, Sara Goldberg, Kosuke Iwasaki, et al.
The Journal of Behavioral Health Services & Research
|
February 14, 2002
Access to new medications to treat schizophrenia
Tami L Mark, Riad Dirani, Eric Slade, et al.
Current Medical Research and Opinion
|
November 2, 2010
Perceptions and prescribing considerations among US psychiatrists regarding drug-drug interactions associated with oral atypical antipsychotics
Christian Frois, Annie Guerin, Amit Saraogi, et al.
Page
of 4